SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
68 hedge funds and large institutions have $321M invested in Syros Pharmaceuticals, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 65 → 68 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
68
Holding in Top 10
2
Calls
$931K
Puts
$3K
Top Buyers
| 1 | +$21.3M | |
| 2 | +$18.3M | |
| 3 | +$10.1M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$8.38M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.99M |
Top Sellers
| 1 | -$833K | |
| 2 | -$762K | |
| 3 | -$743K | |
| 4 |
Millennium Management
New York
|
-$637K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$370K |